A Study of LY2157299 in Participants With Pancreatic Cancer That is Advanced or Has Spread to Another Part of the Body
Status:
Completed
Trial end date:
2015-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and side effects of LY2157299 in
combination with gemcitabine in Japanese participants with pancreatic cancer that is advanced
or has spread to another part of the body.